✦ LIBER ✦

P.411 The impact of age on sustained virological response in genotype 1 HIV-HCV co-infected patients receiving peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®): AIDS PEGASYS ribavirin co-infection trial (APRICOT)

✍ Scribed by J. Rockstroh; F.J. Torriani; M. Rodriguez Torres; E. Lissen; A. Lazzarin; J. De Pamphilis; N. Clumeck; B. Clotet; R. Sola; D. Dieterich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

507 Early prediction of sustained virolo

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

522 Combination therapy with peginterfer

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Impact of the peginterferon-α 2a and rib

✍ Torres-Cornejo, A.; Ruiz-Valderas, R.; Jimenez-Jimenez, L.; Abad-Molina, C.; Gut 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB